FDA establishment 3008002401, Changping, China. Part of Lepu Medical Technology (Beijing) Co., Ltd.'s FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations and its recalls since 2016.
FY2018 to FY2027 to date; 0 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
Inspections citing each reference
| Mar 6, 2026 | Devices · Compliance: Devices | None posted | No Action Indicated (NAI) |
| Nov 23, 2023 | Devices · Postmarket Assurance: DevicesDevices · Compliance: Devices | None posted | Voluntary Action Indicated (VAI) |
| Feb 5, 2015 | Devices · Compliance: Devices | 2 cited references
| Voluntary Action Indicated (VAI) |
| Recalled product | Class | Classified |
|---|---|---|
| Leccurate SARS-CoV-2, Antibody Rapid Test Kit (Colloidal Gold Immunochromatography), 1 test, IVD. for…Device · Z-1619-2021 · 2 products | Class I | Apr 26, 2021 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports